Catalyst Wire Dossier Catalyst Wire Dossier

ZX008

fenfluramine hydrochloride · Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ZX008, covering 2022-10-19 to 2026-07-02. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants [Phase 1]

See pricing